MedTrace Logo

Study of How People Make Decisions About Prostate Cancer Risk

NCT07197723 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-04-22

No results posted yet for this study

Summary

The purpose of this study is to learn how people with BRCA1/2 mutations respond to genetic risk modifier testing. The researchers will learn more about how people make choices about their health care, including about methods to screen for prostate cancer. Researchers are also doing this study to learn about how the genetic risk modifier test affects people's thoughts and feelings.

Conditions

  • BRCA1/2
  • Geneitic Testing

Interventions

GENETIC

cheek (buccal) swab

swab sample in person or at home with a mailed test kit and will fill out a survey

OTHER

Assessments

about 1 week, 6 months, and 12 months after getting the updated cancer risk assessment to complete additional surveys.

OTHER

optional collection of blood

for research testing

Sponsors & Collaborators

Principal Investigators

  • Jada Hamilton, PhD, MPH · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-25
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07197723 on ClinicalTrials.gov